This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10 - 16 July and includes updates on COVID-19, monkeypox, measles, West Nile virus, Vibrio growth in the Baltic Sea and mass gathering for Hajj.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 June-2 July 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, plague, dengue, polio, chikungunya and cholera.
This scientific report provides an overview of highly pathogenic avian influenza (HPAI) virus detections in poultry, captive and wild birds as well as noteworthy outbreaks of low pathogenic avian influenza (LPAI) virus in poultry and captive birds, and human cases due to avian influenza virus that occurred in and outside Europe between 16 March and 10 June 2022.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the the period 12-18 June 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, Mycobacterium chelonae in bioprosthetic heart valves and avian influenza.
This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, measles and MERS-CoV.
This reporting protocol is intended for reporting national case-based data for surveillance of hepatitis of unknown origin from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.
This document provides guidance on diagnostic testing, molecular characterisation and metagenomic analysis for suspect cases of severe acute hepatitis of unknown aetiology.
This report provides an overview of the cases of hepatitis of unknown origin in children aged 16 years and below reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).